Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell therapy for the treatment of relapsed or…
Tag:
Grants
-
-
Agrochemicals
FDA Grants AppliedVR Approval for First Virtual Reality Therapeutic to Treat Chronic Low Back Pain.
by adminby adminSUMMARY: The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive…
-
Diroximel Fumarate
The European Commission Grants Marketing Authorization for VUMERITY® (Diroximel Fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis.
by adminby adminSYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…
-
Active Pharmaceutical Ingredients (API)Covaxin
WHO grants Most-awaited Emergency Use Listing to Bharat Biotech’s Covaxin.
by adminby adminSUMMARY: WHO grant of EUL will ease international travel for those vaccinated with the Bharat Biotech`s Covaxin and the WHO clearance is a…
-
CabotegravirRilpivirine
European Commission Grants Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV
by adminby adminSUMMARY: ViiV Healthcare announces the European Commission Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an…